Form D · Biotechnology
selectIon, Inc.
San Diego, CA · CIK 0001777508
Offering snapshot reported Sep 15, 2025 · SEC filing
- Reported sold
- $5.43M Offering amount: $20M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Sep 8, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 15, 2025 | Initial | $5,430,646 | No comparison | 5 | SEC filing |
| Jun 5, 2023 | Initial | $5,002,772 | No comparison | 9 | SEC filing |
| Apr 8, 2021 | Initial | $5,059,996 | No comparison | Not reported | SEC filing |
| May 31, 2019 | Initial | $4,094,057 | No comparison | 8 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-557520
Source: Form D, filed Sep 15, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Foster | Director |
| Cam Gallagher | Director |
| Andreas Klostermann | Director |
| Antonius Schuh | Director, Executive |
| Don Scifres | Director |
| Don Scrifes | Director |
| Mark Wiggins | Director |
| Steve Zaniboni | Executive |
| Stephen Zaniboni | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
655 India Street Suite 204
San Diego, CA, 92101
San Diego, CA, 92101